Skip to main content

MS Clinical Trials in Georgia

19 active trials · 10 recruiting

19 active multiple sclerosis clinical trials have at least one study site in Georgia, 10 of them currently recruiting participants. Trials are listed from ClinicalTrials.gov and cover disease-modifying therapies, symptom treatments, rehabilitation and imaging studies.

Eligibility, contact details and the exact site address are on each trial's ClinicalTrials.gov record, linked from every trial page. MS Buddy also lists 10 MS treatment centers in Georgia; many trial sites are run from those centers, and your neurologist is the best first person to ask about joining a study.

Active MS trials with sites in Georgia

RecruitingNA

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Sponsor: SetPoint Medical Corporation
Procedure/Surgery: Implant Procedure · Disease-Modifying Therapies (DMTs)
4 states60 participantsDetails ›
RecruitingPhase 1

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Sponsor: National Cancer Institute (NCI)
Biospecimen Collection · Nivolumab
19 states300 participantsDetails ›
RecruitingPhase 3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Sponsor: Sanofi
Frexalimab · Teriflunomide
35 states1600 participantsDetails ›
Recruiting

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

Sponsor: TG Therapeutics, Inc.
No intervention
4 states16 participantsDetails ›
RecruitingPhase 1

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

Sponsor: Georgia State University
Ublituximab
1 state25 participantsDetails ›
RecruitingNA

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

Sponsor: Georgia State University
Perturbation Training · Treadmill Walking
1 state64 participantsDetails ›
By invitation onlyNA

Effects of Stimulation Patterns of Deep Brain Stimulation

Sponsor: Duke University
Therapeutic Stimulation Patterns · Symptogenic Stimulation Patterns
3 states180 participantsDetails ›
Closed to new patientsPhase 4

Effects of Ocrevus in Relapsing Multiple Sclerosis

Sponsor: Georgia State University
Ocrelizumab · Platform
1 state60 participantsDetails ›
Closed to new patientsPhase 3

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Sponsor: Novartis Pharmaceuticals
Ofatumumab approved dose · Ofatumumab new dose
24 states196 participantsDetails ›
Closed to new patientsPhase 3

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

Sponsor: Novartis Pharmaceuticals
Ofatumumab · Tetanus toxoid (TT) containing vaccin…
32 states1882 participantsDetails ›
Closed to new patientsPhase 3

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Sponsor: Sanofi
Tolebrutinib · Placebo
27 states2500 participantsDetails ›
Closed to new patientsPhase 3

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Sponsor: Hoffmann-La Roche
Ocrelizumab
26 states1300 participantsDetails ›
Closed to new patients

Biobank For MS And Other Demyelinating Diseases

Sponsor: Accelerated Cure Project for Multiple Sclerosis
9 states3226 participantsDetails ›
Closed to new patientsNA

MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect

Sponsor: Ad scientiam
MSCopilot® Detect mobile application
10 states336 participantsDetails ›
Closed to new patientsPhase 2

Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis

Sponsor: Immunic AG
IMU-838 · Placebo matching IMU-838
6 states450 participantsDetails ›

MS trials in other states

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play